Anna Protopapas

Anna Protopapas is Chief Executive Officer & Director at Flare Therapeutics, Inc. since 2026 and Independent Chairman at Nuvalent, Inc. since 2022.
Former roles include President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014, Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017, Director at Ensemble Therapeutics Corp., Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021, Director at Mersana Therapeutics, Inc. from 2023 to 2026, Director at Bioverativ, Inc. from 2017 to 2018, Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014, and Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Princeton University, and an MBA from Stanford Graduate School of Business.